Rhythm Pharmaceuticals Grants Inducement Equity Covering 56,080 Shares To Ten New Employees
Portfolio Pulse from Benzinga Newsdesk
Rhythm Pharmaceuticals has granted inducement equity covering 56,080 shares to ten new employees, including options for 9,230 shares and RSUs for 46,850 shares.
June 11, 2024 | 8:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Rhythm Pharmaceuticals has granted inducement equity covering 56,080 shares to ten new employees, including options for 9,230 shares and RSUs for 46,850 shares.
The issuance of inducement equity is a common practice to attract new talent. While it may lead to a slight dilution of existing shares, it is generally seen as a neutral event in the short term.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100